Cover Image
市場調查報告書

Ensoltek Co., Ltd.的產品平台分析

Ensoltek Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 317367
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Ensoltek Co., Ltd.的產品平台分析 Ensoltek Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年04月30日 內容資訊: 英文 23 Pages
簡介

Ensoltek Co., Ltd.是總公司位於韓國的生物資訊學及生物科技企業,利用創新的生物資訊學技術開發新的生醫材料產品,並研發新的的藥物標的和抗生素標的等。

本報告提供Ensoltek Co., Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Ensoltek Co., Ltd.的基本資料

  • Ensoltek Co., Ltd.概要
  • 主要資訊
  • 企業資料

Ensoltek Co., Ltd.:R&D概要

  • 主要的治療範圍

Ensoltek Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

Ensoltek Co., Ltd.:開發中產品概況

  • 初期階段產品開發中產品
    • 藥物研發中的產品/聯合治療模式

Ensoltek Co., Ltd.:藥物簡介

  • Hesed-1000
  • Hesed-2000
  • Hesed-3000
  • Hesed-4000
  • Hesed-5000
  • Nephesh-1000
  • Peniel-3000
  • Peniel-5000

Ensoltek Co., Ltd.:開發平台分析

  • 各分子類型

Ensoltek Co., Ltd.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07009CDB

Summary

Global Markets Direct's, 'Ensoltek Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Ensoltek Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ensoltek Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ensoltek Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ensoltek Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ensoltek Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Ensoltek Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ensoltek Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ensoltek Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ensoltek Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ensoltek Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ensoltek Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ensoltek Co., Ltd. Snapshot
    • Ensoltek Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Ensoltek Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Ensoltek Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • Ensoltek Co., Ltd. - Pipeline Products Glance
    • Ensoltek Co., Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Ensoltek Co., Ltd. - Drug Profiles
    • Hesed-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-2000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-3000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-4000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Hesed-5000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Nephesh-1000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peniel-3000
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peniel-5000
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ensoltek Co., Ltd. - Pipeline Analysis
  • Ensoltek Co., Ltd. - Pipeline Products by Molecule Type
  • Ensoltek Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ensoltek Co., Ltd., Key Information
  • Ensoltek Co., Ltd., Key Facts
  • Ensoltek Co., Ltd. - Pipeline by Indication, 2015
  • Ensoltek Co., Ltd. - Pipeline by Stage of Development, 2015
  • Ensoltek Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Ensoltek Co., Ltd. - Out-Licensed Products in Pipeline, 2015
  • Ensoltek Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • Ensoltek Co., Ltd. - Discovery, 2015
  • Ensoltek Co., Ltd. - Pipeline by Molecule Type, 2015

List of Figures

  • Ensoltek Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Ensoltek Co., Ltd. - Out-Licensed Products in Pipeline, 2015
  • Ensoltek Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top